4//SEC Filing
Sit Swan 4
Accession 0001437749-22-013458
CIK 0001389545other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 7:28 PM ET
Size
6.4 KB
Accession
0001437749-22-013458
Insider Transaction Report
Form 4
Sit Swan
Director
Transactions
- Exercise/Conversion
Common Stock
2022-05-21+30,000→ 30,000 total - Exercise/Conversion
Restricted Stock Units
2022-05-21−30,000→ 30,000 total→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001801128
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 7:28 PM ET
- Size
- 6.4 KB